4P-Pharma raises €15M; Oncotelic Therapeutics sells rights to cancer assets
Plus, news about Adaptilens:
4P-Pharma secures €15M in second closing: The fundraise, which was backed by private …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.